Long intergenic non-protein coding RNA 331 (LINC00331)

Long intergenic non-protein coding RNA 331 (LINC00331) is a human long non-coding RNA gene that does not code for protein but produces a transcript longer than 200 nucleotides, situated in genomic regions not overlapping protein-coding genes[1][3][5]. Like other lincRNAs, it may be involved in chromatin remodeling, regulation of transcription, and stabilization of other RNA molecules, but no disease role or therapeutic targeting is currently described[1][3][5]. LINC00331 is classified as a long intergenic non-coding RNA (lincRNA), a subtype of long non-coding RNAs (lncRNAs) that do not overlap coding genes and typically exceed 200 nucleotides in length[3][5]. LincRNAs broadly are involved in the regulation of gene expression, chromatin architecture modulation, and can have enhancer-like activity, but there is little detailed functional information about LINC00331 specifically in the current literature[3][5]. No reports in available sources suggest that LINC00331 serves as a therapeutic target (e.g., receptor, enzyme, transporter) or that it is clinically actionable[1][5]. Aliases identified include NCRNA00331, with the NCBI Gene accession number 100874126[5]. No evidence of interaction with drugs, biomarker status, or safety concerns is available at this time[1][5]. The canonical full name in scientific databases is "long intergenic non-protein coding RNA 331," and the standard abbreviation is "LINC00331"[1][5]. If more specific functions or disease roles are reported in future literature, this information may require updating.

Other names

NCRNA00331